title: Treatment of respiratory allergy with allergy immunotherapy tablets.
abstract: Allergy immunotherapy tablets (AIT) have expanded the treatment options for patients suffering from respiratory allergies. Efficacy is established in adults and children for two different commercially available grass AITs. The ALK grass AIT has an efficacy comparable to subcutaneous immunotherapy (SCIT), with a proven disease-modifying effect after treatment completion. Safety profiles favour AIT over SCIT. Studies suggest that tablets in all aspects are superior to sublingual drops. AITs for other allergies including house dust mite and birch and ragweed pollen are in development.
authors.affiliation: Department of Otorhinolaryngology, Upper Airway Research Laboratory, University Hospital Ghent, Belgium. claus.bachert@ugent.be
authors.forename: C
authors.initials: C
authors.lastname: Bachert
mesh_terms: D000286:Administration, Sublingual; D000328:Adult; D000485:Allergens / Q000008:administration & dosage* / Q000276:immunology*; D000818:Animals; D002415:Cats; D028203:Cedrus / Q000276:immunology; D002648:Child; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000628:therapy; D003888:Desensitization, Immunologic; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy*; D007279:Injections, Subcutaneous; D006109:Poaceae / Q000276:immunology*; D011058:Pollen / Q000276:immunology*; D039981:Pyroglyphidae / Q000276:immunology; D016896:Treatment Outcome
chemical_list: D000485:Allergens